Scientific and Medical Equipment House Company (4014.SR)
SAR 51.1
(0.2%)
SAR 51.1
(0.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 362.83 Million SAR | 75.66% |
| 2022 | 206.55 Million SAR | -22.42% |
| 2021 | 266.24 Million SAR | 45.05% |
| 2020 | 183.55 Million SAR | -19.74% |
| 2019 | 228.7 Million SAR | -18.21% |
| 2018 | 279.62 Million SAR | 68.22% |
| 2017 | 166.22 Million SAR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 257.37 Million SAR | -19.67% |
| 2024 Q1 | 320.41 Million SAR | -11.69% |
| 2023 Q4 | 362.83 Million SAR | 4.39% |
| 2023 FY | 362.83 Million SAR | 75.66% |
| 2023 Q3 | 347.58 Million SAR | 11.86% |
| 2023 Q2 | 310.72 Million SAR | 18.68% |
| 2023 Q1 | 261.81 Million SAR | 26.75% |
| 2022 Q3 | 286.07 Million SAR | -15.81% |
| 2022 Q2 | 339.81 Million SAR | 8.79% |
| 2022 FY | 206.55 Million SAR | -22.42% |
| 2022 Q1 | 312.34 Million SAR | 17.32% |
| 2022 Q4 | 206.55 Million SAR | -27.8% |
| 2021 Q2 | 254.12 Million SAR | 0.0% |
| 2021 Q1 | - SAR | -100.0% |
| 2021 FY | 266.24 Million SAR | 45.05% |
| 2021 Q4 | 266.24 Million SAR | 0.0% |
| 2020 FY | 183.55 Million SAR | -19.74% |
| 2020 Q1 | - SAR | 0.0% |
| 2020 Q4 | 188.55 Million SAR | 0.0% |
| 2020 Q3 | 188.55 Million SAR | 0.0% |
| 2019 FY | 228.7 Million SAR | -18.21% |
| 2018 FY | 279.62 Million SAR | 68.22% |
| 2017 FY | 166.22 Million SAR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|